ANIP ANI Pharmaceuticals Inc

NASDAQ

$71.65

ANI Pharmaceuticals Inc (ANIP) Earnings News

Earnings press releases, previews and reviews for ANI Pharmaceuticals Inc (ANIP), newest first. Our most recent is review: ANI Pharmaceuticals Beats on Diversified Strength, but a Second Cortrophin Guidance Cut Overshadows the Egetis Deal.

Thursday November 5, 2026 10:46 AM ET

ANI Pharmaceuticals Beats on Diversified Strength, but a Second Cortrophin Guidance Cut Overshadows the Egetis Deal

Earnings Whispers · Review

Thursday November 5, 2026 6:51 AM ET

ANI Pharmaceuticals Reports Third Quarter 2026 Financial Results

Wednesday October 28, 2026 1:05 PM ET

ANI Pharmaceuticals Needs Cortrophin to Hit Its Trimmed Third-Quarter Guide as the Gout Launch Faces Scrutiny

Earnings Whispers · Preview

Friday October 23, 2026 6:55 AM ET

ANI Pharmaceuticals to Discuss Third Quarter 2026 Financial Results on November 5, 2026 at 8:00 a.m. ET

Friday August 7, 2026 6:50 AM ET

ANI Pharmaceuticals Reports Record Second Quarter 2026 Financial Results

Friday July 24, 2026 6:50 AM ET

ANI Pharmaceuticals to Discuss Second Quarter 2026 Financial Results on August 7, 2026 at 8:00 a.m. ET

Friday May 8, 2026 6:50 AM ET

ANI Pharmaceuticals Reports First Quarter 2026 Financial Results and Raises 2026 Financial Guidance